Morphine state-dependent learning sensitization and interaction with nitric oxide

Pharmacology

Volumn 78, Issue 2, 2006, Pages 66-71

  Zarrindast, Mohammad Reza ^a,b,c   Askari, Elham ^b   Khalilzadeh, Azita ^a   Nouraei, Negin ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

L Arginine; L NAME; Morphine sensitization; Morphine state dependency

Indexed keywords

ARGININE; MORPHINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIZATION; EXPERIMENTAL STUDY; LEARNING; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; THERAPY EFFECT;

ANIMALS; ARGININE; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DRUG INTERACTIONS; ENZYME INHIBITORS; MALE; MEMORY; MICE; MICE, INBRED STRAINS; MORPHINE; MORPHINE DEPENDENCE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 33749322732     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095541     Document Type: Article

References (38)

1. Castellano C: Effects of morphine and heroin on discrimination learning and consolidation in mice. Psychopharmacologia 1975;42:235-242.
2. Izquierdo I: Effects of naloxone and morphine on various forms of memory in the rat: possible role of endogenous opiate mechanisms in memory consolidation. Psychopharmacology 1979;66:199-203.
3. Bruins Slot LA, Colpaert FC: Opiate states of memory: receptor mechanisms. J Neurosci 1999;23:10520-10529.
4. Bruins Slot LA, Colpaert FC: Recall rendered dependent on an opiate state. Behav Neurosci 1999;113:337-344.
5. Babbini M, Davis WM: Time-dose relationship for locomotor activity effects of morphine after acute or repeated treatment. Br J Pharmacol 1972;46:213-224.
6. Kuribara H: Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. Eur J Pharmacol 1995;275:251-258.
7. Aguilar MA, Minarro J, Simon V: Dose-dependent impairing effects of morphine on avoidance acquisition and performance in male mice. Neurobiol Learn Mem 1998;69:92-105.
8. Robinson TE, Berridge KC: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993;18:247-291.
9. Robinson TE, Berridge KC: Incentive-sensitization and addiction mechanisms of action of addictive stimuli. Addiction 2001;96:103-114.
10. Vanderschuren LJMJ, Kalivas PW: Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of pre-clinical studies. Psychopharmar cology 2000;151:99-120.
11. Holscher C, Rose SPR: An inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neurosci Lett 1992;145:165-167.
12. Bohme GA, Bon C, Lemaire M, Reibaud M, Piot O, Stutzman JM, Doble A, Blanchard JC: Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci USA 1993;90:9191-9194.
13. Baratti SR, Kopf A: A nitric oxide synthase inhibitor impairs memory storage in mice. Neurobiol Learn Mem 1996;65:197-201.
14. Teledgy G, Kokavszky R: The role of nitric oxide in passive avoidance learning. Neuropharmacology 1997;36:1583-1587.
15. Baratti SR, Boccia MM: Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav Pharmacol 1999;10:731-737.
16. Brignola G, Calignano A., Di Rosa M: Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol 1994;113:1372-1376.
17. Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GW: Blockade of tolerance to morphine but not to κ opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 1993;90:5162-5166.
18. Cuellar B, Fernandez AP, Lizasoain I, Moro MA, Lorenzo P, Bentura ML, Rodrigo J, Leza JC: Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology 2000;148:66-73.
19. Benamar K, Xin L, Geller EB, Adler MW: Effect of central and peripheral administration of a nitric oxide synthase inhibitor on morphine hyperthermia in rats. Brain Res 2001;894:266-273.
20. Homayoun H, Khavandgar S, Namiranian KH, Gaskari SA, Dehpour AR: The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res 2002;48:33-41.
21. Khavandgar S, Homayoun H, Zarrindast MR: The effect of L-NAME and L-arginine on impairment of memory formation and state-dependent learning induced by morphine in mice. Psychopharmacology 2003;167:291-296.
22. G-nitro-L- arginine methyl ester. Life Sci 1993;52:PL245-PL249.
23. Kimes AS, Vaupel DB, London ED: Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology 1993;112:521-524.
24. Dambisya YM, Lee TL: Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 1996;117:914-918.
25. Hall S, Milne B, Jhamandas K: Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study. Brain Res 1996;739:182-191.
26. Leza JC, Lizasoain I, Cuellar B, Moro MA, Lorenzo P: Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn Schmiedebergs Arch Pharmacol 1996;353:349-354.
27. Majeed NH, Przewlocka B, Machelska H, Przewlocki R: Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 1994;33:189-192.
28. Vaupel DB, Kimes AS, London ED: Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur J Pharmacol 1997;324:11-20.
29. Nishimura M, Shigi Y, Kaneto H: State-dependent and/or direct memory retrieval by morphine in mice. Psychopharmacology 1990;100:27-30.
30. Khavandgar S, Homayoun H, Torkaman-Boutorabi A, Zarrindast MR: The effects of adenosine receptor agonists and antagonists on morphine state-dependent memory of passive avoidance. Neurobiol Learn Mem 2002;78:390-405.
31. Zarrindast MR, Dinkoub Z, Homayoun H, Bakhtiarian A: Dopamine receptor mechanism(s) and morphine tolerance in mice. J Psychopharmacol 2002;16:261-266.
32. Jeziorski M, White FJ: Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur J Pharmacol 1995;275:235-244.
33. Scheggi S, Masi F, Tagliamonte A, Gambarana C, Tolu P, De Mentis MG: Rats sensitized to morphine are resistant to the behavioral effects of an unavoidable stress. Brain Res 2000;853:290-298.
34. Shippenberg TS, Heidbreder CH, Lefevour A: Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol 1996;299:33-39.
35. Zarrindast MR, Rezayof A: Morphine state-dependent learning: sensitization and interactions with dopamine receptors. Eur J Pharmacol 2004;497:197-204.
36. Serrano A, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J: Effects of DA, D1 and D2 antagonists on the sensitization to the motor effects of morphine in mice. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:1263-1271.
37. Bhargava HN: Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen Pharmacol 1995;26:1049-1053.
38. Highfeld DA, Grant S: N-Nitro-L-arginine, a NOS inhibitor, reduces tolerance to morphine in the rat locus coeruleus. Synapse 1998;29:233-239.